Certain Sleep-Disordered Breathing Treatment Mask Systems and Components Thereof; Notice of the Commission's Determination To Review an Initial Determination Amending the Complaint and Notice of Investigation; Affirmance of the Initial Determination With Modified Reasoning, 8544-8545 [2019-04243]

Download as PDF 8544 Federal Register / Vol. 84, No. 46 / Friday, March 8, 2019 / Notices INTERNATIONAL TRADE COMMISSION [Investigation Nos. 731–TA–929–931 (Third Review)] Silicomanganese From India, Kazakhstan, and Venezuela; Scheduling of Expedited Five-Year Reviews United States International Trade Commission. ACTION: Notice. AGENCY: The Commission hereby gives notice of the scheduling of expedited reviews pursuant to the Tariff Act of 1930 (‘‘the Act’’) to determine whether revocation of the antidumping duty orders on silicomanganese from India, Kazakhstan, and Venezuela would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time. DATES: December 10, 2018. FOR FURTHER INFORMATION CONTACT: Christopher W. Robinson, (202–202– 2542), Office of Investigations, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these reviews may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Background.—On December 10, 2018, the Commission determined that the domestic interested party group response to its notice of institution (83 FR 44898, September 4, 2018) of the subject five-year reviews was adequate and that the respondent interested party group response was inadequate in each review. The Commission did not find any other circumstances that would warrant conducting full reviews.1 Accordingly, the Commission determined that it would conduct expedited reviews pursuant to section 751(c)(3) of the Tariff Act of 1930 (19 U.S.C. 1675(c)(3)).2 Due to the lapse in SUMMARY: 1 A record of the Commissioners’ votes, the Commission’s statement on adequacy, and any individual Commissioner’s statements will be available from the Office of the Secretary and at the Commission’s website. 2 Chairman Johanson and Commissioner Broadbent voted to conduct full reviews. VerDate Sep<11>2014 16:24 Mar 07, 2019 Jkt 247001 appropriations and ensuing cessation of Commission operations, the Commission tolled its deadlines in these reviews. For further information concerning the conduct of these reviews and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A and B (19 CFR part 201), and part 207, subparts A, D, E, and F (19 CFR part 207). Staff report.—A staff report containing information concerning the subject matter of the reviews will be placed in the nonpublic record on March 7, 2019, and made available to persons on the Administrative Protective Order service list for these reviews. A public version will be issued thereafter, pursuant to section 207.62(d)(4) of the Commission’s rules. Written submissions.—As provided in section 207.62(d) of the Commission’s rules, interested parties that are parties to the reviews and that have provided individually adequate responses to the notice of institution, and any party other than an interested party to the reviews may file written comments with the Secretary on what determinations the Commission should reach in the reviews. Comments are due on or before March 12, 2019 and may not contain new factual information. Any person that is neither a party to the five-year reviews nor an interested party may submit a brief written statement (which shall not contain any new factual information) pertinent to the reviews by March 12, 2019. However, should the Department of Commerce (‘‘Commerce’’) extend the time limit for its completion of the final results of its reviews, the deadline for comments (which may not contain new factual information) on Commerce’s final results is three business days after the issuance of Commerce’s results. If comments contain business proprietary information (BPI), they must conform with the requirements of sections 201.6, 207.3, and 207.7 of the Commission’s rules. The Commission’s rules with respect to filing were revised effective July 25, 2014. See 79 FR 35920 (June 25, 2014), and the revised Commission Handbook on E-filing, available from the Commission’s website at https:// edis.usitc.gov. In accordance with sections 201.16(c) and 207.3 of the rules, each document filed by a party to the reviews must be served on all other parties to the reviews (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Determinations.—The Commission has determined these reviews are extraordinarily complicated and therefore has determined to exercise its authority to extend the reviews period by up to 90 days pursuant to 19 U.S.C. 1675(c)(5)(B). Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. By order of the Commission. Issued: March 4, 2019. Katherine Hiner, Acting Secretary to the Commission. [FR Doc. 2019–04170 Filed 3–7–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1134] Certain Sleep-Disordered Breathing Treatment Mask Systems and Components Thereof; Notice of the Commission’s Determination To Review an Initial Determination Amending the Complaint and Notice of Investigation; Affirmance of the Initial Determination With Modified Reasoning U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined to review the presiding administrative law judge’s (‘‘ALJ’’) initial determination (‘‘ID’’) (Order No. 11) amending the complaint and notice of investigation to reflect a corporate name change of complainant ResMed Ltd to ResMed Pty Ltd. FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2737. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired SUMMARY: E:\FR\FM\08MRN1.SGM 08MRN1 Federal Register / Vol. 84, No. 46 / Friday, March 8, 2019 / Notices persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on October 4, 2018, based on a complaint, as supplemented, filed on behalf of ResMed Corp. of San Diego, California, ResMed Inc. of San Diego, California, and ResMed Ltd. of Bella Vista, Australia (collectively, ‘‘Complainants’’). 83 FR 50,121 (October 4, 2018). The complaint, as supplemented, alleges violations of Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (‘‘section 337’’), based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain sleep-disordered breathing treatment mask systems and components thereof by reason of infringement of certain claims of U.S. Patent No. 9,119,931; U.S. Patent No. 9,027,556; U.S. Patent No. 9,962,511; U.S. Patent No. 9,962,510; U.S. Patent No. 9,937,315. The complaint further alleges that an industry in the United States exists as required by section 337. The notice of investigation named Fisher & Paykel Healthcare Limited of Auckland, New Zealand; Fisher & Paykel Healthcare, Inc. of Irvine, California; and Fisher & Paykel Healthcare Distribution Inc. of Irvine, California as respondents. The Office of Unfair Import Investigations is not participating in this investigation. On February 13, 2019, the Complainants filed an unopposed motion for leave to amend the complaint and notice of investigation to reflect a corporate name change of one of the complainants from ResMed Ltd to ResMed Pty Ltd. Complainants argued that good cause exists and that there would be no harm to the public interest. On February 14, 2019, the ALJ issued the subject ID, granting complainants’ unopposed motion. The ID found that good cause exists to amend the complaint and notice of investigation. The ID also noted that there was no opposition to the motion. No petitions for review were filed. The Commission has determined to review the ID. On review, the Commission affirms the ID’s finding that good cause has been shown. The Commission further finds that the amendment to the notice of investigation and complaint would not prejudice the public interest. The VerDate Sep<11>2014 16:24 Mar 07, 2019 Jkt 247001 complaint and notice of investigation are amended to reflect the corporate name change from ResMed Ltd to ResMed Pty Ltd. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: March 5, 2019. Katherine Hiner, Acting Secretary to the Commission. [FR Doc. 2019–04243 Filed 3–7–19; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Petroleum Environmental Research Forum Notice is hereby given that, on February 22, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Petroleum Environmental Research Forum (‘‘PERF’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, CH2MHill, Englewood, CO; GeoSyntec Consultants, Inc., Boca Raton, FL; Syncrude Canada, Ltd., Edmonton, CANADA; Test America, Inc., Parker, CO; Nalco, Sugar Land, TX; and Trihydro, Laramie, WY, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PERF intends to file additional written notifications disclosing all changes in membership. On February 10, 1986, PERF filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 14, 1986 (51 FR 8903). The last notification was filed with the Department on January 29, 1019. A PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 8545 notice was published in the Federal Register pursuant to Section 6(b) of the Act on February 14, 2019 (84 FR 4103). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–04193 Filed 3–7–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Halon Alternatives Research Corporation, Inc. Notice is hereby given that, on February 21, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Halon Alternatives Research Corporation, Inc. (‘‘HARC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Airbus S.A.S.1, Toulouse, FRANCE and Honeywell, Morris Plains, NJ, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and HARC intends to file additional written notifications disclosing all changes in membership. On February 7, 1990, HARC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 7, 1990 (55 FR 8204). The last notification was filed with the Department on March 9, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on April 10, 2017 (82 FR 17281). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–04195 Filed 3–7–19; 8:45 am] BILLING CODE 4410–11–P E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 84, Number 46 (Friday, March 8, 2019)]
[Notices]
[Pages 8544-8545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04243]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1134]


Certain Sleep-Disordered Breathing Treatment Mask Systems and 
Components Thereof; Notice of the Commission's Determination To Review 
an Initial Determination Amending the Complaint and Notice of 
Investigation; Affirmance of the Initial Determination With Modified 
Reasoning

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined to review the presiding administrative law 
judge's (``ALJ'') initial determination (``ID'') (Order No. 11) 
amending the complaint and notice of investigation to reflect a 
corporate name change of complainant ResMed Ltd to ResMed Pty Ltd.

FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office 
of the General Counsel, U.S. International Trade Commission, 500 E 
Street SW, Washington, DC 20436, telephone (202) 205-2737. Copies of 
non-confidential documents filed in connection with this investigation 
are or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired

[[Page 8545]]

persons are advised that information on this matter can be obtained by 
contacting the Commission's TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on October 4, 2018, based on a complaint, as supplemented, filed on 
behalf of ResMed Corp. of San Diego, California, ResMed Inc. of San 
Diego, California, and ResMed Ltd. of Bella Vista, Australia 
(collectively, ``Complainants''). 83 FR 50,121 (October 4, 2018). The 
complaint, as supplemented, alleges violations of Section 337 of the 
Tariff Act of 1930, as amended, 19 U.S.C. 1337 (``section 337''), based 
upon the importation into the United States, the sale for importation, 
and the sale within the United States after importation of certain 
sleep-disordered breathing treatment mask systems and components 
thereof by reason of infringement of certain claims of U.S. Patent No. 
9,119,931; U.S. Patent No. 9,027,556; U.S. Patent No. 9,962,511; U.S. 
Patent No. 9,962,510; U.S. Patent No. 9,937,315. The complaint further 
alleges that an industry in the United States exists as required by 
section 337. The notice of investigation named Fisher & Paykel 
Healthcare Limited of Auckland, New Zealand; Fisher & Paykel 
Healthcare, Inc. of Irvine, California; and Fisher & Paykel Healthcare 
Distribution Inc. of Irvine, California as respondents. The Office of 
Unfair Import Investigations is not participating in this 
investigation.
    On February 13, 2019, the Complainants filed an unopposed motion 
for leave to amend the complaint and notice of investigation to reflect 
a corporate name change of one of the complainants from ResMed Ltd to 
ResMed Pty Ltd. Complainants argued that good cause exists and that 
there would be no harm to the public interest.
    On February 14, 2019, the ALJ issued the subject ID, granting 
complainants' unopposed motion. The ID found that good cause exists to 
amend the complaint and notice of investigation. The ID also noted that 
there was no opposition to the motion. No petitions for review were 
filed.
    The Commission has determined to review the ID. On review, the 
Commission affirms the ID's finding that good cause has been shown. The 
Commission further finds that the amendment to the notice of 
investigation and complaint would not prejudice the public interest. 
The complaint and notice of investigation are amended to reflect the 
corporate name change from ResMed Ltd to ResMed Pty Ltd.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: March 5, 2019.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2019-04243 Filed 3-7-19; 8:45 am]
 BILLING CODE 7020-02-P